Previously, we developed a series of physiologically based pharmacokinetic (PBPK) models for manganese (Mn) in which saturable tissue binding and dose-dependent increases in biliary excretion captured key aspects of Mn homeostasis biology. These models reproduced the non-linear behavior of Mn kinetics in different tissues, accounting for dose-dependent changes in Mn kinetics. The original model construct had relatively slow association and dissociation rate constants for Mn binding in tissues. In this updated model, both rates of entry into tissue and the interaction of Mn with binding sites are rapid, and the step limiting Mn accumulation is the saturation of tissue binding sites. This binding reflects general cellular requirements for Mn with high affinity but rapid exchange between bound and free forms, which we captured using a dissociation constant (KD) of0
Introduction
Mn is an essential element and present in all tissues in significant concentrations. The best-known role of Mn in the body is as a redoxactive cofactor in the cellular antioxidant defense enzymes such as Mnsuperoxide dismutase (Aschner et al., 2007) . Tissue Mn concentrations are maintained at a relatively constant level despite widely varying levels of Mn input from dietary intake ranging from 1 to 10 mg Mn per day in humans (ATSDR, 2013; Freeland-Graves, 1994 ). This tight control of body Mn is attributable to multiple homeostatic processes: 1) uptake in the gut, 2) storage and utilization in the tissue, and 3) biliary excretion (Aschner et al., 2005; Teeguarden et al., 2007) . However, exposure to excessive Mn such as chronic inhalation of high doses Mn (over 1 mg Mn/m 3 ) can overwhelm the homeostasis leading to toxicity in the central nervous system (CNS) (Andersen et al., 2010; Roels et al., 1999) . Other excessive exposure conditions such as long-term parenteral nutrition containing Mn and/or impaired Mn clearance due to liver dysfunction can also compromise homeostatic regulation of Mn and lead to elevated CNS target tissue concentration (Leyva-Illades et al., 2014; Santos et al., 2014) .
A series of PBPK models has been developed for Mn considering both essentiality and toxicity to support a human health risk assessment of Mn exposure (Nong et al., 2009 . The models are intended to predict exposure conditions that would lead to toxicologically significant increases in Mn concentrations in the target tissue compared to the levels maintained with normal dietary intake. These models are based on the knowledge of the biological factors that control uptake, distribution, and clearance of Mn and other essential trace metals that were available at the time of model development. To describe the dose-dependent pharmacokinetic behavior of Mn observed in multi-dose, multi-route and multi-species pharmacokinetic studies, it was necessary to describe Mn homeostasis as the underlying reason for those dose-dependent kinetics behavior (Andersen et al., 2010) . The introduction of these biological processes was accomplished using the concept of saturable tissue binding and inducible biliary excretion.
The published models effectively reproduced the non-linear behavior of Mn kinetics in different tissues. However, the knowledge gained about Mn homeostasis in recent years indicates that metal homeostasis depends primarily on regulation of uptake into and efflux out of tissues via various cellular membrane metal transporters and less on avid binding of Mn within tissues (Aschner and Erikson, 2017; Chen et al., 2015) . Recent studies have shown that several of the zinc transporter proteins are crucial in Mn homeostasis in addition to those already known such as the divalent metal transporter 1 (DMT1) and transferrin/transferrin receptor system. Notably, SLC30A10, SLC39A8 and SLC39A14 have shown to be pivotal in Mn clearance and maintenance of Mn homeostasis in vertebrates (Chen et al., 2015; Leyva-Illades et al., 2014; Lin et al., 2017; Tuschl et al., 2016) . Compared to Mn importers, transporters for Mn efflux and the underlying mechanisms of Mn efflux and their role in maintaining Mn homeostasis in mammalian systems have been discovered only recently. Among those, SLC30A10 appear to be the most relevant Mn efflux transporters playing a role in mediating Mn efflux in neuronal systems (Chen et al., 2015; Hutchens et al., 2017; Leyva-Illades et al., 2014) .
In this study, we evaluated an alternative model structure that is more consistent with the recent understanding of the biology of essential metal transport across the cell membrane through metal transporters rather than one relying on the description of tissue binding processes controlling elimination rates for Mn. While the published models have successfully served their roles in supporting internal exposure-based Mn risk assessment, the new model structure will facilitate the incorporation of data from emerging in vitro and in vivo models on Mn transport, enabling the mechanism-based refinement of the model structure, and should lead to increased confidence in model applications.
Materials and methods

Model structure
Two rat Mn PBPK models are compared in this study (Fig. 1 ). The published model (Nong et al., 2008 ) is referred as 'binding' or 'original' model, whereas the model newly introduced here is referred to as 'transporter', 'rapid binding/dissociation' or 'updated' model. Note that saturable tissue storage and asymmetric diffusion in and out of the tissue are key determinants of tissue Mn in both models (Fig. 1) . Only the relative rates of these processes are different between the two models. Therefore, this update of the model can be viewed as a reparameterization of the original model described in Nong et al. (2008) .
Original model
The basic structure of the existing PBPK models describing Mn kinetics in multi-species with multi-exposure routes for rodents, primates and humans is based on the 'original' model developed in the rat (Nong et al., 2009) . Most of the features in the Nong model were maintained in the updated model. Only the features that are notably different in the new model are detailed below. For other details of the published model, Nong et al. (2009) should be referred to.
Briefly, Mn is rapidly cleared into the tissues after entering the systemic circulation regardless of exposure routes. For brain, this clearance was described as an asymmetric bi-directional diffusion. The free Mn in systemic blood rapidly equilibrates with free Mn in the blood of the brain tissue. The flux between brain tissue-blood and brain tissue is diffusion limited, the rate of which is determined by the diffusion rate constants, kin and kout, respectively. In the original model, the diffusion limitation in the brain was considered to reflect the role of bloodbrain barrier in controlling Mn in and out fluxes.
The feature of asymmetrical diffusion was included in a brain region-specific fashion, a decision that was rationalized due to different requirements for basal manganese in different regions and differential distribution of transporters. The asymmetrical diffusion is necessary to describe the preferential uptake of Mn into the mid-brain seen with high levels of Mn exposure. For other tissues, a rapid and symmetrical flux of Mn between the systemic blood and tissue compartment was included using a partition coefficient, and thus, the tissue Mn in these other tissue compartments is primarily determined by the tissue binding characteristics.
Once distributed into the tissue, Mn is 'bound' to the cellular components that require Mn for a variety of biological functions, i.e., utilized in the cell. Bound Mn is not readily available to diffuse from tissue to blood. The 'binding' capacity, therefore, represents a total pool of accessible binding partners for manganese. The model structure does not attempt to differentiate between different enzymes, proteins, etc. with which Mn associates within tissues. The incorporation of Mn into these cellular proteins/tissue constituents and subsequent loss from those 'binding sites' back to blood are governed by three model parameters -maximum tissue binding capacity (Bmax) and tissue specific association and dissociation rate constants (ka and kd, respectively). Initial estimates of Bmax were based on the basal levels of manganese in various tissues.
The fraction bound (or fraction free) in the tissue varies dependent on the Mn content in diet at steady-state. At normal dietary intakes, the majority of Mn in the tissue will be associated with cellular M. Yoon, et al. Toxicology and Applied Pharmacology 372 (2019) 1-10 constituents, i.e., 'bound'. With sufficiently high Mn in diet, the fraction of Mn in the tissue in a bound form, i.e., Mn_bound/(Mn_bound + Mn_free), would be lower than the same ratio in animals on a marginal Mn diet. The fraction bound expressed in this manner does not directly represent the actual occupancy of binding sites. In high-dose exposure, binding sites would be eventually saturated, and the fraction free could exceed the fraction bound. In such cases, free Mn -the form believed to be related to effects in target tissues -increases disproportionately compared to the increase in external dose. Free Mn circulates in blood and is the form excreted into bile. The bound form is in the tissue and dissociates from the binding sites with a rate constant kd. A key factor differentiating the two models is the magnitude of kd: it was smaller in the original model and larger in the updated model.
The updated model
In the original model, dissociation of bound forms of Mn was slow (Table 1 ) and designed to be the limiting process for loss of Mn when body and tissue stores were reduced by alterations in intake or at the end of high dose exposures. In this updated model, the dissociation (and association) rate constants are much larger and tissue stores adjust more rapidly to alterations in Mn intake and total body burden.
These higher rates of tissue binding and the consistency of the dissociation equilibrium constant across tissues are more reflective of the biology of interactions of Mn with tissue proteins. The use of a common dissociation constant (KD) at 0.5 μM is more consistent with similarities in Mn utilization and requirements across tissue types and leads to maintenance of Mn in bound forms until the binding sites become saturated. The variability in the presumed binding capacities across tissues still accounts for different background levels of Mn in particular tissues as in the Nong et al. (2008) model, as they reflect differing degrees of Mn demands among different tissues. Using a KD of approximately 0.5 μM for all tissues, about 70% of Mn in tissues in the basal state is bound.
Model parameterization
All the physiological and chemical-specific parameters other than those updated (Table 1) were kept the same as the previously published binding model (Nong et al., 2008) .
In our revised model, uptake of Mn to all the tissues, not just brain regions, is mediated by a tissue uptake rate constant rather than blood flow directly. This membrane transport is tissue dependent allowing differential increases in Mn in the target tissues after high-dose-rate exposures of Mn. Describing all transport as linear processes captured the kinetics both for steady-state and inhalation exposure conditions, i.e., there is no need to introduce dose-dependent transport rate constants across cellular membranes.
To convert parameter values from the original to the updated model, the following steps were taken. Briefly, the association rate constant (ka) was set at 10/μM/h to allow rapid complexing of Mn to binding partners in all the tissues. The corresponding dissociation rate constant (kd) was calculated to obtain a KD of around 0.5 μM in all the tissues. The uptake rate constant parameter (KinC) was set to give smaller uptake clearances (Kin in the unit of ml/h) for brain and bone (i.e., limited uptake), and higher uptake clearances for other tissues, in particular for liver (Table 1) . Efflux parameters (KoutC) for each tissue were fitted to be consistent with the tissue concentrations both during steady-state conditions and during inhalation exposures that increase tissue Mn.
The new model could recapitulate dose-dependent increases in biliary excretion without biliary induction, and so the model structure was finalized as such.
Model evaluation and sensitivity analysis
Experimental data used for model evaluation
To compare the performance of the original and the updated models, three data sets from rat pharmacokinetic studies were used. They were collected both in steady-state dietary and inhalation exposure conditions and were used for model development and evaluation of the original model as well. A brief description of these studies is given below.
• Steady-state dietary exposure study -Rats were maintained on a diet containing Mn at 2, 10, and 100 ppm for over 11 weeks. Both tissue steady-state Mn concentrations and elimination kinetics for an intravenous tracer administration of 54 MnCl 2 without inhalation exposure data were reported and used for model evaluation (Dorman et al., 2001a ).
• Fourteen-day inhalation study -Rats were exposed to soluble MnSO 4 at concentrations of 0, 0.03, 0.3 or 3 mg Mn/m 3 for 14 consecutive days for 6 h/day in addition to a 125 ppm (approximately 100-150 ppm) dietary Mn exposure. Tissue concentrations of Mn as well as the 54 Mn tracer (which was administered at the end of the 14 day inhalation exposure) kinetics at the end of the 14 day exposure period from this study were used for model evaluation (Dorman et al., 2001b ).
• Ninety-day inhalation study -Rats were fed a 10 ppm Mn diet and exposed via inhalation to MnSO 4 at concentrations of 0.1 or 0.5 mg/ m 3 for 6 h/day and 5 days/week with weekends off, over a 90-day period. Tissue Mn concentrations were reported at 45-and 90-day after the cessation of the inhalation exposure (Dorman et al., 2004) .
Sensitivity analysis
A sensitivity analysis of the original and the updated models was performed for 6 key model parameters, ones that had been shown to have a high sensitivity for striatal Mn in the original model (Nong et al., 2008) . The 6 parameters included influx and efflux rates into and out of Table S1 in Supplementary materials for cerebellum, lung and liver).
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Model simulations
All the model simulations were run using acslX (version 3.0.2.1; The Aegis Technologies Group, Inc., Huntsville, Alabama). Model fitting/ parameter optimization was performed using the automated parameter optimization function in acslX based on NelderMead algorithm. The model code is available from the corresponding author upon request.
Results
Simulation of whole-body Mn tracer kinetics in steady-state and inhalation exposure
The time course of the intravenously injected 54 Mn elimination kinetics was determined in rats on three different diets, containing Mn at 2, 10 or 100 ppm, at steady-state (Dorman et al., 2001a) . The simulation of the loss of 54 Mn from the body was fairly well described with either the original parameters or with the updated model structure (Fig. 2) . A second tracer study was conducted in rats exposed to various concentrations of MnCl 2 by inhalation for 14 days in rats fed on an approximately 125 ppm diet (Dorman et al., 2001b) . The tracer was administered intravenously at the end of the 14-day inhalation exposure; hence the tracer kinetics reflected how the total amount of Mn in the body changes immediately after the inhalation exposure stops. The updated model with rapid binding provided a slightly better fit to both the more rapid initial loss of Mn from the body and maintenance of tracer Mn at the later times at the three different dietary intakes (Fig. 4) . As with diet alone, the rapid binding/dissociation model provided a more accurate description of the loss of tracer over time as the body returned to a basal condition after brief periods of high concentration exposure to Mn via tracer injection (Figs. 3 and 4) .
Simulation of brain Mn kinetics in steady-state and inhalation exposure
The simulated striatum concentrations from both models were consistent with the observed total tissue Mn concentrations at steady state following administration of dietary Mn concentrations ranging from 2 to 100 ppm in the Dorman et al. (2001b) study (Fig. 5) . Also, both models reproduced the observed striatum Mn concentrations at the end of the 14 day inhalation exposure (Fig. 5) reported in Dorman et al. (2001a) . The updated model produced a more rapid rise in striatum Mn along with a greater daily fluctuation over the time course of the simulation. Similarly, the updated model performed marginally better in capturing the time profiles of striatum Mn after 90 day inhalation exposure (Fig. 5C ). In particular, the updated model was able to better recapitulate a time profile of rapid elimination and return to steady state after the cessation of the last inhalation dosing as was shown with 0.5 mg Mn/m 3 .
Comparison of the simulated Mn kinetics in free and bound Mn forms
Figs. 5 and C clearly showed that the updated model shows more extensive short-term excursions, although both models recapitulated the observed tissue concentrations during and at the end of inhalation exposure equally well. Updated model simulated striatum Mn kinetics in free vs. bound forms were plotted (Fig. 6) showing that striatum Mn time profiles are predominantly determined by the increase in free Mn in the updated model. This was also the case in the original model (Nong et al., 2009) , although with much less short term excursions, particularly in the later refined original model (Nong et al., 2008) as is shown in Fig. 5-A. 
Sensitivity analysis of binding and transporter model parameters
The results of the sensitivity analysis of the updated and the published original models performed for the 6 key model parameters that were shown to be highly influential to striatum Mn concentrations in the binding model were plotted for steady state (Fig. 7A ), 14-day inhalation ( Fig. 7B ) and 90-day inhalation (Fig. 7C) . In contrast to the earlier model sensitivity analysis, the updated model with more rapid binding and dissociation shows significant sensitivity for both the uptake and efflux rate constants in and out of the striatum, whereas with the original model, the striatum Mn concentration is sensitive to both transport and binding rates. 54 Mn tracer total body radioactivity in rats fed on a 2, 10 or 100 ppm Mn diet for 13 weeks in the same study. Intravenous injection of 54 MnCl 2 was done following the 13-week diet, and the whole-body Mn radioactivity was measured for 10 weeks post-injection exposure.
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Discussion
Previously published PBPK models were developed based on the available knowledge of the biological determinants of the uptake, distribution, and clearance for Mn and included aspects of the factors important for the distribution of Mn as they were known at the time of model development (Nong et al., 2008; Schroeter et al., 2011; Yoon et al., 2011) . Because of the limitations in the understanding of the biological steps involved in essential metal homeostasis, the parameters of these PBPK models did not necessarily have a one-to-one correspondence to specific biological and/or biochemical processes in Mn homeostasis and disposition in the body. In particular, the mechanism of cellular transport and utilization in different tissues under various exposure conditions had not been fully characterized when those models were being developed and when the structure of the initial models were finalized. As such, the primary goal in developing the previously published PBPK models was to have a model structure that captured the dose-dependent kinetics of Mn observed in rodents and, indirectly, provided confidence in utilizing a similar model structure for humans. Although the original model structure and parameters were based on particular assumptions about processes controlling Mn within tissues, they still allowed coherent integration of the known Mn biology at the time of model development, recapitulating the observed tissue Mn concentrations in various tissues within the body under various exposure conditions, and accounting for exposures that would lead to tissue overload and rapid increases in free Mn in tissues. In both the original and this updated model structure, Mn time profiles in striatum after inhalation are predominantly determined by the increase in free Mn. As the free Mn, i.e., the form of Mn that is not associated with cellular macromolecules, is assumed to be responsible for Mn toxicity, this indicates that the predicted dose-response relationships from the two models would be similar. The processes accounting for the increase in free Mn with increasing tissue Mn differ in the original and this updated model. In the original models, slow dissociation rate constants provided the rate determining process for allowing Mn to exit the tissue. In this rapid equilibration model, the exchange between bound and free forms is rapid, and efflux rates from the tissues determine the rate at which free Mn leaves the tissues.
In the updated model, the KD values are similar among different tissues and consistent with similar utilization patterns for cellular Mn regardless of the tissue types. Differing amounts of Mn in various tissues -i.e., different levels of Mn containing macromolecules, lead to different background tissue Mn capacities in both models. While the KD in our updated model reflects a general binding affinity of multiple Mnbinding sites in tissues, there is little direct information about the amounts or affinity of these binding partners. Some experimental studies reported the cellular free Mn in rat hepatocytes at around 0.2 to 1 μM using the electron paramagnetic resonance analysis technique (Ash and Schramm, 1982; Powell and Brew, 1976) . In addition, a few experimental studies reported dissociation constants for Mn binding/ association to cellular macromolecules such as galactosyltransferase and Mn 2+ -ATPase in a low micromolar range (Grisham and Mildvan, 1974; Powell and Brew, 1976) . These estimates are in line with the physiological cellular concentration of free Mn and consistent with the KD we selected for our simulations. Kinetics of Mn tracer in the whole body can be viewed as a reflection of free Mn behaviors under given exposure conditions, e.g., in the current study they were steady-state dietary or the end of inhalation exposure. Mn tracers are incorporated into cellular macromolecules, i.e., bound, and then released from those binding sites into the free form in the cell and subsequently exit the cells to blood for excretion to bile. The improvement with the updated model in providing better correspondence with tracer kinetics compared to the original model shows that the transients after changing exposure conditions need to be more rapid than allowed in the earlier description. The updated description also better captured the rapid clearance of circulating free Mn from Dorman et al. (2001b) , whereas the lines represent model simulations using the published (A) or updated (B) model for striatum Mn concentrations in rats fed on 2, 10 or 100 ppm Mn diet for 13 weeks reported in the same study. Fig. 5B . 14 day inhalation brain striatum Mn concentration. Symbols represent the mean ± SD of the data reported by Dorman et al. (2001a) , whereas the lines represent model simulations using the published (A) or updated (B) model for striatum Mn concentrations in rats exposed by inhalation to 0.03, 0.3 and 3 mg Mn/m 3 for 6 h/d for 14 consecutive days (Dorman et al., 2001a) . Steady state conditions are achieved more quickly in the updated model. . The rats were fed on a 10 ppm diet from 30 d prior to exposure, and then they were exposed for 13 weeks for 6 h/d, 5 d/week with weekends off.
Fig. 5. (continued)
M. Yoon, et al. Toxicology and Applied Pharmacology 372 (2019) 1-10 blood resulting from inhalation exposure, producing a more rapid rise in striatum Mn along with a greater daily fluctuation of total Mn in its time profile as well as a rapid return to the basal level at the cessation of the inhalation. Indeed, the updated model recapitulated the Mn elimination kinetics with changes in Mn intake much better that had been done previously. The clear improvement in capturing Mn-transients, although either model recapitulates longer-exposure tissue dose-response, indicates that the updated tissue description may be particularly useful in investigating mechanisms of Mn toxicity in cell culture models and nonmammalian systems such as zebrafish or C. elegans. PK models can be used in these situations to describe Mn kinetics in the culture system itself, cellular loading and unloading of Mn from and to the media, which can then facilitate the extrapolation of in vitro mechanistic M. Yoon, et al. Toxicology and Applied Pharmacology 372 (2019) 1-10 findings and dose-response relationships to corresponding in vivo conditions. For example, the new Mn model could provide a useful insight into the intracellular trafficking and efflux of Mn leading to better understanding of the concentration-dependent control of Mn transports via metal transporters at cellular surfaces as well as the intracellular movement of Mn in relation with cellular toxicity in in vitro models such as primary neuronal cells and model organisms such as C. elegans (Leyva-Illades et al., 2014; Lin et al., 2017) . With the rapid association/dissociation rates in this updated model, it was no longer necessary to include induction of the biliary excretion rate constant as body burdens of Mn increased (Fig. S1 ). The simulated dose-dependent rate of, or amount of, Mn excretion by the updated model remained comparable to that simulated by the original model indicating that in the new description, free Mn-dependent biliary excretion alone is sufficient to describe dose-dependent changes in Mn excretion via bile. This difference occurs because in the updated model, the saturation of binding sites throughout the body and more rapid increases in blood Mn drive the rate of biliary excretion rather than requiring enhancement of the rate constant to effectively provide a draw on tissue Mn in the face of the slow dissociation constant for tissue stores of Mn.
For the published models, the tissue binding and cellular transport parameters for rat striatum were allometrically scaled to monkey globus pallidus together with further optimization based on the available tissue time course data in monkeys (Nong et al., 2008; Schroeter et al., 2011) . Inter-species extrapolation of the monkey pallidal parameters to those in humans was also based on the allometrical scaling along with the available human data Yoon et al., 2011) . Currently, we are investigating the feasibility of updating the monkey model with the rapid binding assumption as described in this study. Once successfully evaluated, inter-species extrapolation of the updated monkey model to human can be performed in a similar manner to the published models.
Since the motivation for recasting the Nong et al. (2008) model structure to this rapid association-dissociation model was the increasing appreciation of transporters in controlling metal kinetics and tissue accumulation, it is of interest to consider recent work on Mn-metal transporters and Mn toxicity in mice. Over the past two years research Fig. 7 . Determinants of striatum Mn -comparison between the original vs. updated models. Sensitivity analysis was performed for 6 key parameters to test how sensitive the brain striatum Mn concentration is in response to a small change in each of these parameters. The resulting sensitivity coefficients are plotted here. Abbreviations for those 6 parameters are influx and efflux rates into and out of the striatum (KINSTC and KOUTSTC), association and dissociation rate constants in the striatum (KAST and KDST), the biliary excretion rate constant (KBILEC), and the absorption fraction in the gut (FDIETUP).
has appeared evaluating the role of two Mn efflux transporters, SLC39A14 and SLC30A10. The work with both transporters used transgenic mice. With SLC39A14 (Xin et al., 2017) , wild-type, whole body knock out (KO) and hepatocyte specific KOs were evaluated. For similar Mn intakes, the whole-body KO mice had 20 to 30-fold increases in blood and brain Mn compared to WT-mice. With the liver specific KOs, except for relatively small increase in liver itself, there was little change in Mn in other tissues. The study with SLC39A14 also evaluated the effect of the KO on other transporters, finding modest changes in another Mn-efflux transporter, SLC30A10, in several tissues.
A more extensive evaluation was reported with SLC30A10 (Taylor et al., 2019) using 5 strains of mice: WT, whole body KO, hepatocyte KO, endoderm specific KOs (i.e., KOs in both the liver and GI-tract), and pan-neuronal/glial KO. Whole body KOs increased brain Mn by about 20-fold and blood Mn by 20-to 25-fold. As with SLC39A14, liver specific KOs caused only small changes in blood and brain Mn. The endoderm specific KOs had increases in blood and brain Mn nearly as great as those seen in whole body KO mice. Surprisingly, the pan-neuronal/glial KOs had minimal increases in brain Mn compared to WT-mice.
The appearance of these new data sets on differential tissue Mn accumulation with manipulation of specific transporters represents an opportunity to further develop our restructured model with more explicit inclusion of transporter tissue distribution. As has been the practice with many other PBPK modeling programs, the ability to include different structural characteristics within models, in this case, different distributions and activities of transporters, together with different model structures, such as this rapid association-dissociation model, should provide important quantitative tests to what might remain qualitative conclusions about the influence of different tissue distributions of transporters on tissue accumulation of Mn.
Some of the observations with tissue specific KO mice are consistent with prior work from the nutritional literature on regulation of uptake with changing diets. Teeguarden et al. (2007) examined the uptake of Mn with increasing dietary Mn showing that the rate constant for uptake, a measure of the ability of Mn to move to the enterocyte and out was reduced 23-fold going from dietary intake of 0.49 to 73 ppm, while the rate of biliary excretion increased only by a factor of 4 (data from Malecki et al., 1996) . These changes and other work showed that uptake from the gut to the circulation was under tight control. These processes indicated a primary role of enterocyte elimination of Mn in controlling the proportion retained from the diet rather than the biliary excretion after absorption. Clearly, the primacy of enterocyte function in controlling Mn homeostasis is also evident from these liver specific transporter KO mice. The role of biliary excretion is to move Mn into bile where it also is sensed by enterocytes. The most intriguing observation is the lack of brain accumulation in the pan-neuronal/glial KO mice. This behavior might indicate a role for SLC30A10 in intake as well as efflux at higher blood Mn or the presence of coordinate effects on expression of other efflux transporters in the SLC30A10 KO mice.
Our modeling efforts over the past decade have focused on uptake and distribution of Mn after inhalation exposures with animals or humans (Yoon et al., 2014) . With inhalation, and uptake of Mn from the lungs, the control of uptake by enterocytes primarily affects the proportion Mn retained from the diet with the liver moving Mn from blood to the intestinal lumen. The increasing knowledge of tissue distribution and function in these transgenic mice coupled with species-specific PBPK modeling should be useful for informing risk assessments for both oral and inhalation exposures.
It also bears some emphasis that this recast rapid-association-dissociation PBPK model can be easily adapted to account for transporter distribution and for the characteristics of kinetic parameters of transporters in diverse tissues as such data become available. These models, as with those derived from the older model architecture, are also readily amenable to inclusion of life stage changes in the concentrations of transporters in animals and humans and for different life stages (Yoon et al., 2014) .
Conclusion
Our alternative parameterization in an updated PBPK model successfully describes Mn kinetics in tissues in adult rats exposed to Mn both in their diet and by inhalation. The model structure with rapid binding was better in capturing transient dose dependent elimination processes of the tracer as dosing patterns and dose levels changed. However, the two model structures -with different kinetics of tissue binding -both capture the dose-dependent and tissue-specific kinetic behavior of Mn in adult rats for longer-term exposure conditions. The equivalent performance of the published and updated models in capturing the non-linear kinetics of Mn provides greater confidence in using the previously published Mn PBPK models in risk assessment, as updating the other published Mn models to incorporate the alternative parameterization is unlikely to lead to materially different outcomes when modeling changes in Mn concentration under different exposure conditions once steady-state is reached. The updated model has promise for extending the application of the Mn PBPK model to develop studies on mechanism-based toxicity testing approaches, in particular focusing on the target brain regions of mid-brain for Mn neurotoxicity such as striatum and globus pallidus (Aschner et al., 2005; Dorman et al., 2000) , incorporate those new data on Mn transporters from non-animal and other emerging alternative models to the PBPK models for in vitro to in vivo extrapolation, and study periods of rapid changes in Mn exposures in various populations. Such abilities will also contribute to adding weight of evidence increasing confidence in model-based risk assessment.
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